Electronic Triggers: Microhematuria Trigger

NCT ID: NCT05011253

Last Updated: 2022-07-14

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 2000 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2021-10-06
• Study Completion Date: 2022-06-06

Brief Summary

The research team will evaluate the effectiveness of an InBasket Results message that prompts providers to place appropriate follow up orders.

Detailed Description

The research team will evaluate the effectiveness of an InBasket Results message that prompts providers to place appropriate follow up orders. The message will notify users that a patient has clinically significant microscopic hematuria and is at high risk for underlying malignancy and will include the official recommendations (imaging with a CT urogram, urology evaluation with cystoscopy).

Conditions

Hematuria

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: SCREENING
• Blinding Strategy: DOUBLE

Study Groups

Intervention

The group which will receive the InBasket message to notify users that a patient has clinically significant microscopic hematuria and makes recommendations for follow-up.

Group Type: EXPERIMENTAL

Electronic Trigger Microhematuria Alert

Intervention Type: OTHER

To evaluate the effectiveness of an InBasket Results message in prompting providers to place appropriate follow up orders. The message will notify users that a patient has clinically significant microscopic hematuria and is at high risk for underlying malignancy and will include the official recommendations (imaging with a CT urogram, urology evaluation with cystoscopy).

Control

The group which will not receive the InBasket message to notify users that a patient has clinically significant microscopic hematuria. (Standard practice)

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

Electronic Trigger Microhematuria Alert

To evaluate the effectiveness of an InBasket Results message in prompting providers to place appropriate follow up orders. The message will notify users that a patient has clinically significant microscopic hematuria and is at high risk for underlying malignancy and will include the official recommendations (imaging with a CT urogram, urology evaluation with cystoscopy).

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• 35 years of age or older
• 3+ RBC on Urinalysis
• Urinalysis sent during an outpatient encounter
• any of the following: 60 years of age or older; RBC > 25; current or prior tobacco use; Gross Hematuria

Exclusion Criteria

• Under 35 years of age
• Cystoscopy within 1 year prior to Urinalysis
• Nitrite positive AND Leukocyte Esterase positive
• Nitrite positive AND >100 WBC
• Leukocyte Esterase positive AND >100 WBC
• Know GU cancer diagnosis
• Urinalysis ordered by urology provider

• Minimum Eligible Age: 35 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

NYU Langone Health

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Saul Blecker, MD

Role: PRINCIPAL_INVESTIGATOR

NYU Langone Health

Locations

NYU Langone

New York, New York, United States

Countries

United States

Other Identifiers

QI-MH

Identifier Type: -

Identifier Source: org_study_id